-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Research background :
Research background Research background :Given that the 2017 American College of Physicians guidelines advocate symptomatic treatment rather than target serum uric acid in the treatment of gout management methods, the use of serum uric acid as a treatment target and outcome measurement method has caused controversy
Given that the 2017 American College of Physicians guidelines advocate symptomatic treatment rather than target serum uric acid in the treatment of gout management methods, the use of serum uric acid as a treatment target and outcome measurement method has caused controversy
Research Method Research Method
The researchers analyzed patient-level data from two randomized trials of uric acid-lowering therapy for gout patients conducted in Nottingham, UK and New Zealand
The researchers analyzed patient-level data from two randomized trials of uric acid-lowering therapy for gout patients conducted in Nottingham, UK and New Zealand
The primary outcome was to compare the proportion of participants who had at least one attack of gout in serum uric acid responders and non-responders, and the secondary outcome was the average number of episodes per participant per month for 12 to 24 months
Research results Research results :
From the combined individual data of the two trials, the researchers identified 343 serum uric acid responders and 245 serum uric acid non-responders
From the combined individual data of the two trials, the researchers identified 343 serum uric acid responders and 245 serum uric acid non-responders
Summary summary :
Achieving a mean serum uric acid concentration of less than 6 mg/dL is related to the absence of gout attacks in gout patients and a decrease in the number of gout attacks in the following 12 months
Achieving a mean serum uric acid concentration of less than 6 mg/dL is related to the absence of gout attacks in gout patients and a decrease in the number of gout attacks in the following 12 months
Source:
Stamp, Lisa K et al.
Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials.
The Lancet Rheumatology, Volume 0, Issue 0
.Stamp, Lisa K et Al Association or BETWEEN serum urate and Flares in people with Gout and Evidence for Surrogate Status:.
Analysis of Secondary TWO A randomized Controlled Trials of The Lancet Rheumatology, Volume 0, Issue 0
in this message
